JPRN-UMIN000006974尚未招募未知
Research of Aldosterone Breakthrough by Aliskiren - Research of Aldosterone Breakthrough by Aliskiren
Control of organ function, Kanazawa University Hospital0 个研究点目标入组 200 人开始时间: 2011年12月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Pregnancy or Breastfeeding 2)Malignant hypertension, secondary hypertension 3)Patients with severe cardiovascular deseases or history(history of acute coronary syndrome, stroke within 6 month) 4)Patients with severe liver damage 5)Hypersensitivity of aliskiren or valsartan 6)Patients who receive Hormone replacement therapy 7)Anyconditions not suitable for the participation in this trial judged by the investigator
研究者
相似试验
招募中
不适用
Restoration of Aldosterone Breakthrough by AliskireHypertensionJPRN-UMIN000006154Division of Cardiology, Keio University School of Medicine200
进行中（未招募）
1 期
Pilot study of aprepitant effect on aldosterone secretion in diabetic patient with hypertension associated with low reniDiabetic patient (diabetes mellitus) with hypertension associated with low reninMedDRA version: 18.1Level: HLTClassification code 10052741Term: Endocrine and metabolic secondary hypertensionSystem Organ Class: 100000004866MedDRA version: 18.1Level: PTClassification code 10012601Term: Diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2015-001501-14-FRRouen University Hospital20
尚未招募
不适用
Clinical significance of plasma aldosterone concentration in patients with primary aldosteronismPrimary aldosteronismJPRN-UMIN000016201Department of Metabolic Medicine, Osaka University Graduate School of Medicine750
进行中（未招募）
不适用
Identification of aldosterone-producing adenomas using [68Ga]Ga-PentixaFor PET/CTPrimary aldosteronismMetabolic and Endocrine - Other endocrine disordersACTRN12619001738112Monash Health - Department of Endocrinology34
招募中
3 期
Evaluation of spironolactone on heart related mortality and morbidity among patients undergoing chronic kidney dialysisCTRI/2019/06/019703Population Health Research Institute